AUBURNDALE, Mass. & GALWAY, Ireland--(BUSINESS WIRE)--Cappella Inc., developer of advanced stenting systems for the treatment of coronary bifurcation disease, is pleased to announce its participation in the Cardiovascular Research Foundation’s (CRF) 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
